Bringing COVID-19 vaccines to the public (Podcast Episode 51)

This episode is shared from Mayo Clinic Q&A.

Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Danielle (DeeDee) J. Stiepan

Once a vaccine to prevent COVID-19 is approved, there will be logistics to consider. For example, who will receive the vaccine first, and how can the supply chain safely deliver the vaccine to 330 million Americans and potentially more than 7 billion people worldwide? In addition, multiple vaccines may be brought to market within weeks to months of each other, confusing consumers.

On the Mayo Clinic Q&A podcast, Gregory A. Poland, M.D., an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains the challenges of rolling out a COVID-19 vaccine.

This education is supported in part by an independent medical education grant from Pfizer Inc. and is in accordance with ACCME guidelines.

Click here to claim credit and view faculty disclosures. Select Register to begin the credit claim process.

Connect with Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu or on Twitter @MayoMedEd.


Published

September 14, 2020

Created by

Mayo Clinic